Skip to section navigation
Skip to page content

Drug Policy Research Center Quarterly Newsletter

DPRC Quarterly is an electronic newsletter highlighting RAND research on key public policy findings in substance use and drug policy research. The newsletter is free: to subscribe, enter your email in the subscription box to the right and click "Sign Up."

2022

Out-of-Pocket Cost of Naloxone May Keep Many Uninsured from Accessing It
DPRC Quarterly, Issue 27, highlights a new tool for assessing concurrent opioid policies, policies that punish pregnant women, harm assessment framework for crime policy, and more.
Aug 30, 2022
Rapid Changes in U.S. Illegal Fentanyl Market
DPRC Quarterly, Issue 26, highlights alcohol use during COVID, helping sex trafficking victims with substance use issues, the Internet of Bodies, trending research, and more.
May 24, 2022
Opioid Prescribing Declines, but Cuts Are Not Uniform
DPRC Quarterly, Issue 25, highlights funding family involvement in substance use disorder treatment, reducing opioid overdose deaths, trending research, and more.
Feb 7, 2022

2021

Should Past Cannabis Use Prevent Individuals from Joining the Army?
DPRC Quarterly, Issue 24, highlights supervised drug consumption sites, the influence of COVID-19 on treatment facilities, neonatal opioid withdrawal syndrome, and more.
Nov 9, 2021
Federal Cannabis Legalization and Social Equity
DPRC Quarterly, Issue 23, highlights new research on the opiate market in Afghanistan, 24/7 Sobriety Program effectiveness in Montana, state-level opioid policy analyses, and more.
Jul 29, 2021
Most Buprenorphine Prescriptions Are Written by a Small Number of Providers
DPRC Quarterly, Issue 22, highlights new research on tobacco use among youth experiencing homeless, substance use behaviors of service members, the consequences of OxyContin reformulation, and more.
Jun 2, 2021
Illegal Synthetic Opioid Consumption in the Asia-Pacific Region
DPRC Quarterly, Issue 21, highlights new research on synthetic opioids, density of cannabis outlets, opioid litigation, a new gift in support of the Center, and more.
Mar 8, 2021

2020

Newsletter
Being Mindful About Changing Psychedelic Policy
DPRC Quarterly, Issue 20, highlights research on alcohol consumption during the pandemic, levels of substance use disorder stigma among police officers, a RAND prevention research project, and more.
Nov 16, 2020
Newsletter
COVID Relief and Cannabis Legalization
DPRC Quarterly, Issue 19, highlights research on cannabis policy and COVID-19, the effectiveness of naloxone laws, integrated substance use and mental health treatment for veterans, and more.
Aug 31, 2020
Newsletter
Want to Know If a New Drug Crisis Is Growing? Check the Wastewater
DPRC Quarterly, Issue 18, highlights research on wastewater testing, the fentanyl problem in the U.S., state policies related to substance use in pregnancy, alcohol misuse in women, and more.
May 20, 2020
Newsletter
Launching RAND's New Initiative: Opioids Uncharted
DPRC Quarterly, Issue 17, highlights research on teaching skills to reduce DUI recidivism, the fentanyl crisis, policies that punish pregnant women for substance use, and more.
Mar 9, 2020

2019

Newsletter
Early Evidence of the Impact of Cannabis Legalization
DPRC Quarterly, Issue 16, highlights research on cannabis legalization, tackling America's fentanyl problem, cognitive behavioral therapy for first-time DUI offenses, and more.
Nov 8, 2019
Newsletter
The Future of Fentanyl and Other Synthetic Opioids
DPRC Quarterly, Issue 15, highlights research on the size of the American drug market, substance use among service members, the changing cannabis market in Washington state, and more.
Aug 29, 2019
Newsletter
Emerging Divergence: Drug Policy in Asia
DPRC Quarterly, Issue 14, highlights research on direct dispensing of naloxone for opioid-related overdoses, conflicts over supervised drug consumption sites, tobacco and cannabis use among young adults, and more.
May 15, 2019
Newsletter
How the Opioid Crisis Is Driving the Rise in Hepatitis C
DPRC Quarterly, Issue 13, highlights the rise in Hepatitis C after the reformulation of Oxycontin, neonatal abstinence syndrome, adolescent marijuana use and legalization in Washington, and more.
Feb 4, 2019

2018

Newsletter
Considering Heroin-Assisted Treatment and Supervised Consumption Sites in the U.S.
DPRC Quarterly, Issue 12, highlights alternative approaches to the opioid crisis, improving access to opioid treatment, navigating cannabis legalization, and more.
Dec 6, 2018
Newsletter
China's Role in the U.S. Opioid Crisis
DPRC Quarterly, Issue 11, highlights research on China's role in the U.S. opioid crisis, the affect of cannabis advertising on youth, and treating alcohol and opioid use disorder in a primary care setting.
Sep 6, 2018
Newsletter
Strategies to Limit Negative Consequences of Cannabis Use
DPRC Quarterly, Issue 10, highlights research on cannabis advertising and youth, opioid markets and supply, substance use treatment in primary care, and cannabis potency.
May 31, 2018
Newsletter
Complex Link Between Medical Cannabis and Fewer Opioid Deaths
DPRC Quarterly, Issue 9, highlights research on cannabis use and opioid deaths, results of the EU drug strategy, a social media intervention to reduce drug use among individuals experiencing homelessness, cannabis legalization and alcohol consumption, and another barrier to evidence-based prevention and treatment programs.
Feb 20, 2018

2017

Newsletter
Cannabis Potency and Prices in a Newly Legal Market
DPRC Quarterly, Issue 8, highlights research on potency and prices of cannabis in new markets, a web-based alcohol intervention, cannabis legalization in Canada, and recommendations for medical care for opioid addiction.
Nov 15, 2017
Newsletter
What a Scientist Suggests You Tell Your Kids About Legal Marijuana
DPRC Quarterly, Issue 7, highlights research on effective drug education, strategies to reduce deaths from opioid addiction, and penalties for drug possession.
Aug 8, 2017
Newsletter
Reducing Deaths from Heroin and Other Opioids
DPRC Quarterly, Issue 6, highlights research on strategies to reduce morbidity and mortality from heroin and other opioids, marijuana legalization, EU Drugs Strategy, and cocaine consumption in the United States.
May 10, 2017
Newsletter
Trump's Marijuana Options
DPRC Quarterly, Issue 5, highlights research on prescription drug misuse among service members, marijuana markets and legalization, online alcohol advertising, and problem drinking among veterans with combat experience.
Feb 1, 2017

2016

Newsletter
Alternative Sanctions for Drug Offenses in Europe
DPRC Quarterly, Issue 4, highlights research on alternatives to incarceration in Europe, buprenorphine prescribing, and talking to kids about marijuana.
Nov 16, 2016
Newsletter
Growth of the Online Illicit Drugs Trade
DPRC Quarterly, Issue 3, highlights research on the online illicit drugs trade, alcohol advertising, drug and alcohol interventions, and teen drug use.
Aug 24, 2016
Newsletter
Marijuana Legalization: What Everyone Needs to Know
DPRC Quarterly highlights research on marijuana legalization, opioid addiction, drug and alcohol interventions, teen smoking, and internet drug trafficking.
May 3, 2016
Newsletter
Waivers to Prescribe Buprenorphine Increase Access to Opioid Treatment Options
DPRC Quarterly highlights research on Buprenorphine prescribing, medical marijuana users, the 24/7 Sobriety program, and the inaugural Americas Regional Meeting of the International Society for the Study of Drug Policy (ISSDP).
Feb 15, 2016